Active

NEXT GEN PHARMA

Switched

BE0794344975

Rechtspersoon Private limited company 1 establishment

Laurens De Metsstraat 72D, 9620 Zottegem Activiteiten van holdings

Active for

3 year, 9 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 75,736

▼ 32% vs 2024

Profit

Healthy

€ 611,794

▼ 12% vs 2024

Debts

Low

€ 3 million

▼ 22% vs 2024

NEXT GEN PHARMA from Zottegem, company number BE0794344975, closed financial year 2025 with a result of € 611,794 after tax. For that financial year NEXT GEN PHARMA recorded a gross margin of € 75,736 and equity of € 3.2 million. Compared with financial year 2024, the result moved from € 691,805 to € 611,794. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 7, 2026.

What happened at NEXT GEN PHARMA?

What happened at NEXT GEN PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 611,794 (▼ 12% vs 2024). filed late Source: NBB ↗
  • New establishment in Zottegem. KBO
  • Jeremy Coessens became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 508,395 profit in 2023 to € 611,794 profit in 2025.

Paid € 75,477 in corporate taxes since 2023.

Best year ever: 2024, with € 691,805 profit.

A new publication or filing at NEXT GEN PHARMA? We notify you, reason included.

Follow NEXT GEN PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Jeremy Coessens
NEXT GEN PHARMA

Behind NEXT GEN PHARMA is Jeremy Coessens. The shares are held by Jeremy Coessens.

See the full network in the app

Directors

According to the 2025 annual accounts

Jeremy Coessens

Director

Is a shareholder

Also active at: Cophar, PHENIKS

since 2022

Shareholders

Jeremy Coessens · director

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Laurens De Metsstraat 72D box 6

9620 Zottegem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0794.344.975
VAT number
BE 0794.344.975
Registered office
Laurens De Metsstraat 72D bus 6, 9620 Zottegem
Names & denominations
NEXT GEN PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
2 December 2022
Peppol
Active · Active since 2 Dec 2025
Activities · NACE

Activiteiten van holdings

Holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige zakelijke dienstverlening, neg

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What is the enterprise number of NEXT GEN PHARMA?
The enterprise number of NEXT GEN PHARMA is BE0794344975.
What is the address of NEXT GEN PHARMA?
The registered office of NEXT GEN PHARMA is located at Laurens De Metsstraat 72D box 6, 9620 Zottegem.
When was NEXT GEN PHARMA founded?
NEXT GEN PHARMA was founded on 2 December 2022.
What is the main activity of NEXT GEN PHARMA?
The main activity of NEXT GEN PHARMA is "Activiteiten van holdings" (NACE code 64210).
Does NEXT GEN PHARMA have a website?
No website is currently known for NEXT GEN PHARMA.
How much profit did NEXT GEN PHARMA make in 2025?
NEXT GEN PHARMA posted a profit after taxes of € 611,794 in financial year 2025.
What is the revenue of NEXT GEN PHARMA?
As a small company, NEXT GEN PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 75,736.
How many employees does NEXT GEN PHARMA have?
According to the 2025 annual accounts, NEXT GEN PHARMA has 0 full-time equivalents (FTE).
Where can I find the annual accounts of NEXT GEN PHARMA?
NEXT GEN PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of NEXT GEN PHARMA?
According to the 2025 annual accounts, the directors of NEXT GEN PHARMA are: Jeremy Coessens.
Who owns NEXT GEN PHARMA?
Behind NEXT GEN PHARMA is Jeremy Coessens. The shares are held by Jeremy Coessens.
Who are the shareholders of NEXT GEN PHARMA?
According to the 2025 annual accounts, the shareholders of NEXT GEN PHARMA are: Jeremy Coessens.